Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00546364

Public ClinicalTrials.gov record NCT00546364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the effect of ixabepilone plus capecitabine or docetaxel plus capecitabine on shrinking or slowing the growth of metastatic breast cancer in women. The safety of this combination therapy will also be evaluated.

Study identification

NCT ID
NCT00546364
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
R-Pharm
Industry
Enrollment
62 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Mar 10, 2016

2008 – 2010

United States locations

U.S. sites
60
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
Dch Cancer Treatment Center Tuscaloosa Alabama 35401 —
Scripps Cancer Center La Jolla California 92037 —
Cancer Center of Central Connecticut Southington Connecticut 06489 —
Local Institution Newark Delaware 19718 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Local Institution Jacksonville Florida 32209 —
Local Institution Miami Florida 33176 —
Medical Oncology Associates of Augusta, PC Augusta Georgia 30901 —
Local Institution Honolulu Hawaii 96813 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
John W Kugler, MD Peoria Illinois 61615 —
Midwestern Regional Medical Center Zion Illinois 60099 —
Center for Cancer Care at Goshen Health System Goshen Indiana 46526 —
Monroe Medical Associates Munster Indiana 46321 —
Cancer Center of Kansas Wichita Kansas 67214 —
University of Kentucky Lexington Kentucky 40536 —
University Medical Center, Inc Louisville Kentucky 40202 —
Hematology/Oncology Clinic Baton Rouge Louisiana 70809 —
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809 —
Sinai Hospital of Baltimore Baltimore Maryland 21215 —
Center for Cancer & Blood Disorders, PC Bethesda Maryland 20817 —
Jackson Oncology Associates, Pllc Jackson Mississippi 39202 —
The Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003 —
The Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
Howell Office Plaza Howell Township New Jersey 07731 —
Local Institution Newark New Jersey 07112 —
Cooper Hospital, Division of Hematology/Oncology Voorhees Township New Jersey 08043 —
UNM Cancer Center Albuquerque New Mexico 87106 —
New Mexico Cancer Care Associates (NMCCA) Santa Fe New Mexico 87505 —
Arena Oncology Associates, PC Lake Success New York 11042 —
Hematology Oncology Associates of Rockland Nyack New York 10960 —
Gaston Hematology and Oncology Gastonia North Carolina 28054 —
Marion L Shepard Cancer Center Washington North Carolina 27889 —
Akron General Medical Center Akron Ohio 44302 —
Summa Health System Akron Ohio 44304 —
Local Institution Canton Ohio 44710 —
Mid Ohio Oncology/Hematology, Inc, dba The Mark H Zangmeister Center Columbus Ohio 43219 —
Doylestown Hospital Doylestown Pennsylvania 18901 —
Hematology & Oncology Associates of Nepa Dunmore Pennsylvania 18512 —
Regional Hematology Oncology, PC Langhorne Pennsylvania 19047 —
St Mary Medical Center Langhorne Pennsylvania 19047 —
Local Institution Philadelphia Pennsylvania 19140 —
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141 —
Local Institution Woonsocket Rhode Island 02895 —
Charleston Cancer Center Charleston South Carolina 29406 —
Lowcountry Hematology & Oncology, PA Mt. Pleasant South Carolina 29464 —
Santee Hematology/Oncology Sumter South Carolina 29150 —
Sanford Cancer Center Oncology Clinic Sioux Falls South Dakota 57104 —
Kingsport Hematology Oncology Kingsport Tennessee 37660 —
The University of Tennessee Medical Center Knoxville Tennessee 37920 —
Austin Cancer Centers Austin Texas 78759 —
Cancer Specialists of South Texas Corpus Christi Texas 78412 —
Coastal Bend Cancer Center Corpus Christi Texas 78463 —
Edward L Middleman, MD Duncanville Texas 75137 —
Section Chief Medical Oncology Houston Texas 77030 —
Jose A Figueroa, MD Lubbock Texas 79410 —
Southlake Oncology Southlake Texas 76092 —
Peninsula Cancer Institute Newport News Virginia 23601 —
Providence Cancer Center Spokane Washington 99204 —
Leah L Dietrich, MD La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00546364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00546364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →